These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 1347252
21. Absence of p53 gene mutations in primary neuroblastomas. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pelletier J, Gros P. Cancer Res; 1993 Nov 01; 53(21):5269-73. PubMed ID: 8221661 [Abstract] [Full Text] [Related]
22. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K. Cancer Res; 1993 Jan 15; 53(2):368-72. PubMed ID: 8093350 [Abstract] [Full Text] [Related]
23. Mutations of the p53 gene in gliomas from Malay patients. Jafri A, Aziz MY, Ros S, Nizam I. Med J Malaysia; 2003 Jun 15; 58(2):236-42. PubMed ID: 14569744 [Abstract] [Full Text] [Related]
24. p53 gene mutation spectrum in hepatocellular carcinoma. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Cancer Res; 1992 Nov 15; 52(22):6358-64. PubMed ID: 1330291 [Abstract] [Full Text] [Related]
25. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS. Cancer Res; 1994 Aug 15; 54(16):4342-6. PubMed ID: 8044781 [Abstract] [Full Text] [Related]
31. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer]. Kashkin KN, Fleĭshman EV, Chumakov PM, Perevoshchikov AG. Genetika; 1998 Aug 15; 34(8):1049-55. PubMed ID: 9777351 [Abstract] [Full Text] [Related]
32. Loss of heterozygosity and p53 gene mutations in breast cancer. Deng G, Chen LC, Schott DR, Thor A, Bhargava V, Ljung BM, Chew K, Smith HS. Cancer Res; 1994 Jan 15; 54(2):499-505. PubMed ID: 8275488 [Abstract] [Full Text] [Related]
33. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ. Cancer Res; 1993 Apr 15; 53(8):1889-94. PubMed ID: 8467510 [Abstract] [Full Text] [Related]
34. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H. Oncogene; 1990 Oct 15; 5(10):1603-10. PubMed ID: 1979160 [Abstract] [Full Text] [Related]
37. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T. Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572 [Abstract] [Full Text] [Related]
38. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cote RJ, Jhanwar SC, Novick S, Pellicer A. Cancer Res; 1991 Oct 01; 51(19):5410-6. PubMed ID: 1913660 [Abstract] [Full Text] [Related]
39. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing. Badiali M, Iolascon A, Loda M, Scheithauer BW, Basso G, Trentini GP, Giangaspero F. Diagn Mol Pathol; 1993 Mar 01; 2(1):23-8. PubMed ID: 8287222 [Abstract] [Full Text] [Related]
40. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS. Cancer Res; 1994 Jan 01; 54(1):281-5. PubMed ID: 7903205 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]